miDiagnostics
PrivateLast Round
Series D
Dec 4, 2024
Total Funding Raised
$195.74M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
miDiagnostics operates in Healthcare & Life Sciences and is based in Leuven. Its latest recorded funding round was a Series D round in December 2024.
miDiagnostics is a medical devices company that develops rapid, point-of-care diagnostic tests using silicon chip and nanofluidic technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
miDiagnostics Comparables
Compare miDiagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Thermo Fisher Scientific Inc. | 75% | |
| Roche Holding | 74% | |
| Sartorius Aktiengesellschaft | 73% |
For institutional investors. Book with your work email.
miDiagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 4, 2024 | ||||
| Debt | Dec 8, 2021 | ||||
| Series C | Oct 14, 2021 | ||||
| Series B | Mar 26, 2020 | ||||
| Series A | Jun 1, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
miDiagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pamica NV | Series C, Series D, Series B |
| Alychlo | Series C, Series D, Series A, Series B |
| European Investment Bank Group | Debt |
| Johns Hopkins University Endowment | Series A, Series B |
| PMV | Series D, Series A, Series B |
| Smile Invest | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 115% MoM.
- May 16, 2026
Monthly visitors increased 39% MoM.
For institutional investors. Book with your work email.
miDiagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about miDiagnostics's valuation, stock price, and market status.
Is miDiagnostics a public or private company?
miDiagnostics is a private company.
What is the current stock price of miDiagnostics?
miDiagnostics is a private company, so its shares have no public market price. Caplight tracks miDiagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is miDiagnostics worth (valuation)?
Valuation information for miDiagnostics is not publicly available.
Can I buy miDiagnostics stock?
miDiagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was miDiagnostics's last funding round?
miDiagnostics's most recent funding round was Series D on December 4, 2024.
Who are the main investors in miDiagnostics?
Key investors in miDiagnostics include European Investment Bank Group, Smile Invest.
Will miDiagnostics IPO soon?
No public IPO plans have been announced for miDiagnostics.
How can I track miDiagnostics secondary market activity?
Caplight tracks bids, offers, and trades in miDiagnostics's shares on secondary markets.